GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Miami, Florida. The Company’s products include Intelligent Control Automation System (ICAS), Encrypted Control Device (ECD), and Variable Base Encryption Compression (VBEC). ICAS integrates control, telemetry, video, and communications in a seamless interface designed to control complex processes with limited human resources. ICAS offers customized automation solutions that align with the specific requirements of industrial processes without disrupting their current operations. ECD is a multi-platform input/output solution designed to maintain secure control management. VBEC is an efficient compression protocol to enable transmission of AES-256 encryption blocks fragmented into smaller length packets compatible with existing 2.4 GHz airwaves. The firm's subsidiary, GSAC Engineering Corporation, is engaged in the development of technologies for clean energy and industrial security.
How did GSAC's recent EPS compare to expectations?
The most recent EPS for Gelstat Corp is $, expectations of $.
How did Gelstat Corp GSAC's revenue perform in the last quarter?
Gelstat Corp revenue for the last quarter is $
What is the revenue estimate for Gelstat Corp?
According to of Wall street analyst, the revenue estimate of Gelstat Corp range from $ to $
What's the earning quality score for Gelstat Corp?
Gelstat Corp has a earning quality score of A-/58.098907. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Gelstat Corp report earnings?
Gelstat Corp next earnings report is expected in
What are Gelstat Corp's expected earnings?
Gelstat Corp expected earnings is $, according to wall-street analysts.